Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/23/2000 | WO2000015274A1 Collagenous tissue compositions |
03/23/2000 | WO2000015253A1 Human chorionic gonadotropin vaccines |
03/23/2000 | WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
03/23/2000 | WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
03/23/2000 | WO2000015245A2 Stable liquid formulations of botulinum toxin |
03/23/2000 | WO2000015243A1 A method of treatment and agents useful for same |
03/23/2000 | WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |
03/23/2000 | WO2000008160A3 A plant disease resistance signalling gene: materials and methods relating thereto |
03/23/2000 | WO2000008137A3 Transgenic animals having a modified glycoprotein v gene |
03/23/2000 | WO2000000643A3 Methods and reagents for detecting fungal pathogens in a biological sample |
03/23/2000 | WO2000000611A3 14273 receptor, a g-protein coupled receptor |
03/23/2000 | WO2000000599A3 Composition for the induction of apoptosis in target cells |
03/23/2000 | WO2000000597A3 Non-symbiotic plant hemoglobins to maintain cell energy status |
03/23/2000 | WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
03/23/2000 | WO1999067269A9 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof |
03/23/2000 | WO1999066303A3 Identification and use of differentially expressed genes and polynucleotide sequences |
03/23/2000 | WO1999066025A9 Mtbx protein and nucleic acid molecules and uses therefor |
03/23/2000 | WO1999065931A9 Non-enzymatic chemical amidation process |
03/23/2000 | WO1999064057A9 Retinoic acid inducible dna sequences from lung cells |
03/23/2000 | WO1999062938A3 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof |
03/23/2000 | WO1999062931A3 A cell density signal protein suitable for treatment of connective tissue injuries and defects |
03/23/2000 | WO1999061909A3 Methods and compositions for the detection of human herpesvirus |
03/23/2000 | WO1999061619A3 Cell cycle genes, proteins and uses thereof |
03/23/2000 | WO1999060842A3 Plant retroelements and methods related thereto |
03/23/2000 | WO1999060115A3 Proteins and genes useful as tumor markers |
03/23/2000 | WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions |
03/23/2000 | WO1999054473A3 Bacterial yjeq polypeptide family |
03/23/2000 | WO1999054347A3 ALZHEIMER-ASSOCIATED β-AMYLOID BINDING PROTEIN (ERAB) |
03/23/2000 | WO1999053075A3 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants |
03/23/2000 | WO1999053069A3 Cell cycle regulatory proteins cdc2 and pitslre from plants |
03/23/2000 | WO1999053061A3 Tumor associated nucleic acids and uses therefor |
03/23/2000 | WO1999042588A3 Group b streptococcus antigens |
03/23/2000 | WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
03/23/2000 | DE19846979A1 New human and murine G-coupled receptor EDG (endothelial differentiation gene) 6, useful for modulating inflammatory and immune reactions and for treatment of allergy or tumors |
03/23/2000 | DE19841299A1 Novel gene for a variant Gbeta3-subunit of human G-protein useful for determining risk of G-protein dysfunction associated disease |
03/23/2000 | DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection |
03/23/2000 | CA2706859A1 Mammalian transforming growth factor beta - 9 |
03/23/2000 | CA2346262A1 Methods for treatment of degenerative retinal diseases |
03/23/2000 | CA2343898A1 Maize sina orthologue-1 and uses thereof |
03/23/2000 | CA2343654A1 Method for down-regulating osteoprotegerin ligand activity |
03/23/2000 | CA2343577A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/23/2000 | CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | CA2343354A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer |
03/23/2000 | CA2343352A1 A method of treatment and agents useful for same |
03/23/2000 | CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | CA2343313A1 A method of producing a functional immunoglobulin superfamily protein |
03/23/2000 | CA2343104A1 Recombinant protein production in urine |
03/23/2000 | CA2343051A1 Streptococcal c beta protein compositions |
03/23/2000 | CA2343006A1 Compositions and methods for the treatment of immune related diseases |
03/23/2000 | CA2343001A1 Stomach polypeptide zsig28 |
03/23/2000 | CA2342965A1 Leptin induced genes |
03/23/2000 | CA2342958A1 Rna-associated proteins |
03/23/2000 | CA2342833A1 Human gpcr proteins |
03/23/2000 | CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
03/23/2000 | CA2342396A1 Alternatively targeted adenovirus |
03/23/2000 | CA2342395A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
03/23/2000 | CA2342301A1 Human cell junction pdz protein |
03/23/2000 | CA2342243A1 Stable liquid formulations of botulinum toxin |
03/23/2000 | CA2341780A1 Regulatory sequences for root specific or root abundant gene expression in plants |
03/23/2000 | CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization |
03/23/2000 | CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
03/23/2000 | CA2341315A1 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
03/23/2000 | CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1 |
03/23/2000 | CA2340586A1 T-type calcium channel |
03/23/2000 | CA2340583A1 Plant resistance to insect pests mediated by viral proteins |
03/23/2000 | CA2337902A1 Maize replication protein a |
03/22/2000 | EP0987552A2 Diarylsulfonylurea binding proteins |
03/22/2000 | EP0987329A2 Multimeric form of human rhinovirus receptor protein |
03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
03/22/2000 | EP0986759A2 Use of a fluorescent protein for detecting interaction between a target protein and its ligand |
03/22/2000 | EP0986754A1 Synthetic antibiotics |
03/22/2000 | EP0986652A1 Reagents and methods useful for detecting diseases of the urinary tract |
03/22/2000 | EP0986645A1 Proteins having insecticidal activities and method of use |
03/22/2000 | EP0986644A1 Production of erythropoietin by endogenous gene activation |
03/22/2000 | EP0986643A1 Reagents and methods useful for detecting diseases of the breast |
03/22/2000 | EP0986641A1 Grapevine leafroll virus (type 2) proteins and their uses |
03/22/2000 | EP0986640A2 Transgenic fish with tissue-specific expression |
03/22/2000 | EP0986636A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
03/22/2000 | EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
03/22/2000 | EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
03/22/2000 | EP0986533A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
03/22/2000 | EP0986400A1 Integrin ligand, human mindin |
03/22/2000 | EP0986398A1 Method for the production of vaccines against cell surface proteins |
03/22/2000 | EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals |
03/22/2000 | EP0986395A1 Peptide parathyroid hormone analogs |
03/22/2000 | EP0986312A1 Method for treating a lactic raw material containing gmp |
03/22/2000 | EP0986299A2 Plant transformation methods |
03/22/2000 | EP0817792B1 Compositions for the diagnosis, prevention, and treatment of tumor progression |
03/22/2000 | EP0772776B1 Superparamagnetic particles, process for their production and their use |
03/22/2000 | EP0716705B1 Method for the recombinant preparation of proteins in hansenula yeast |
03/22/2000 | EP0690874B1 Materials and methods relating to proteins that interact with casein kinase i |
03/22/2000 | CN1248295A Species-specific genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes |
03/22/2000 | CN1248290A Method for induction of apoptotic cell death in malignant cells, through reduction of the RB to apoptosis inducing proteins ratio |
03/22/2000 | CN1248286A Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B) DNA and uses thereof |
03/22/2000 | CN1247984A Diagnostic marking for human diseases |
03/22/2000 | CN1247899A Construction method of recombinant DNA for expressing interferon in animal's mammary gland |
03/22/2000 | CN1247897A New human neural differentiation factor |
03/22/2000 | CN1050668C Method for early detection of septicaemia and for treatment-accompanying assessment of course of sepsis, as well as means for carrying out said method |
03/21/2000 | US6040496 Use of translationally altered RNA to confer resistance to maize dwarf mosaic virus and other monocotyledonous plant viruses |
03/21/2000 | US6040441 Isolated recombinant cdna which encodes a protein having one or more cysteine containing domains; for diagnosis and therapy |